Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

Please sign in to follow a disease.

← Back to home

Xerient Pharma

Clinical trials sponsored by Xerient Pharma, explained in plain language.

Trials to join now! 1

New combo therapy aims to boost radiation for tough pancreatic tumors

Disease control Recruiting now

This early-phase trial tests a drug called XER-001 (a form of amifostine given through a tube into the small intestine) combined with precise radiation therapy for people with locally advanced pancreatic cancer that cannot be removed by surgery. The study will enroll 36 participa…

Phase 1/2 • Sponsor: Xerient Pharma • Aim: Disease control

Last updated Aug 19, 2026 00:00 UTC